These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12605468)

  • 1. A note on cost-value analysis.
    Østerdal LP
    Health Econ; 2003 Mar; 12(3):247-50; discussion 251-3. PubMed ID: 12605468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a broader view of values in cost-effectiveness analysis of health.
    Menzel P; Gold MR; Nord E; Pinto-Prades JL; Richardson J; Ubel P
    Hastings Cent Rep; 1999; 29(3):7-15. PubMed ID: 10420299
    [No Abstract]   [Full Text] [Related]  

  • 3. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 5. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
    Richardson JR; Olsen JA
    Health Econ; 2006 Mar; 15(3):311-3; discussion 319-22. PubMed ID: 16389655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [QALYs and fairness: health economic approaches to the fairness issue and their problems].
    Klonschinski A; Lübbe W
    Gesundheitswesen; 2011 Oct; 73(10):688-95. PubMed ID: 21259190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationing health care resources. Is the quality-adjusted life-year a helpful guide?
    Warren JM
    Can Fam Physician; 1994 Jan; 40():123-4, 127-8. PubMed ID: 8312748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating societal concerns for fairness in numerical valuations of health programmes.
    Nord E; Pinto JL; Richardson J; Menzel P; Ubel P
    Health Econ; 1999 Feb; 8(1):25-39. PubMed ID: 10082141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Østerdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QALYs: is the value of treatment proportional to the size of the health gain?
    Nord E; Enge AU; Gundersen V
    Health Econ; 2010 May; 19(5):596-607. PubMed ID: 19459186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portfolio evaluation of health programs: a reply to Sendi et al.
    Bridges JF; Terris DD
    Soc Sci Med; 2004 May; 58(10):1849-51. PubMed ID: 15020002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of comparative economic evaluations of therapies and for rational allocation of resources across sectors of health care systems - introduction, advantages, risks].
    Wasem J; Hessel F; Kerim-Sade C
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S12-20. PubMed ID: 11533902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time trade-off method: results from a general population study.
    Dolan P; Gudex C; Kind P; Williams A
    Health Econ; 1996; 5(2):141-54. PubMed ID: 8733106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the lottery equivalents method: a response to Spencer et al.
    Oliver A
    Health Econ; 2006 Mar; 15(3):323-5. PubMed ID: 16432804
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale.
    Elbasha EH; Messonnier ML
    Health Econ; 2004 Jan; 13(1):21-35. PubMed ID: 14724891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much are Americans willing to pay for a quality-adjusted life year?
    Weinstein MC
    Med Care; 2008 Apr; 46(4):343-5. PubMed ID: 18362811
    [No Abstract]   [Full Text] [Related]  

  • 19. Equity, health, care and values: an economist's perspective.
    Zamagni S
    Dolentium Hominum; 1995; 10(1):203-9. PubMed ID: 15839021
    [No Abstract]   [Full Text] [Related]  

  • 20. Concerns for the worse off: fair innings versus severity.
    Nord E
    Soc Sci Med; 2005 Jan; 60(2):257-63. PubMed ID: 15522483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.